The State of Practicing Traditional Methods and Their Effects on Individuals With Cutaneous Leishmaniasis in Turkey

Öz

Background: The aim of this study was to investigate the state of traditional methods used by individuals with cutaneous leishmaniasis (CL) disease and the effects of traditional methods on their health. Materials and Methods: This was a descriptive study. The sample for this study consisted of 232 cutaneous leishmaniasis patients. The research was conducted in the Oriental Sore Treatment Center between January 01, 2020, and March 01, 2021.The research data were collected with a survey. The descriptive statistics were eval-uated with the chi-square test and phi (Φ) and Cramer’s V parameters. A p-value of less than .05 was considered statistically significant. Results: It was observed that 96 people participating in the survey who received treatment with the diagnosis of CL were children and 136 people were adults. It was determined that one of the family members of each patient had previous CL with a rate of 44.9% and that 8.1% of the patients themselves had CL before. While the traditional method is not used in pediatric patients with CL, it was determined that 44.1% of adult patients used the traditional method for securing their disease. Patients using traditional methods mostly (48.3%) bought ready-made ointments from herbalists and applied them to the wounds. 66.7% of the patients suffered from the traditional method they applied. While 10.8% of patients aged 45 years and younger, 74.6% of patients over 45 years of age used traditional methods (p<0.05), and it was observed that there was a negative moderate relationship between age and traditional method usage (Φ =-0,64). While 89.5% of illiterate patients used tra-ditional methods, 13.6% of patients with secondary school or higher education were detected to use traditional methods (p<0,05, V=0,57). Patients with facial wounds preferred to use traditional methods more (p<0,05, V=0,25). Conclusions: This study showed that cutaneous leishmaniasis is still an important public health problem in Şanlıurfa Province in Turkey, and that traditional methods have negative effects on adult patients. Key Words: Cutaneous Leishmaniasis, Şark Çıbanı, Traditional Method, Health, Effect

Anahtar Kelimeler

• Cutaneous Leishmaniasis
• Şark Çıbanı
• Traditional Method
• Health
• Effect

Kutanöz Leishmania (Şark Çıbanı) Hastalığına Sahip Bireylerin Geleneksel Yöntem Kullanma Durumu ve Etkileri, Türkiye

Öz

Amaç: Bu çalışmanın amacı, kutanöz leishmania (KL) hastalığına sahip bireylerin geleneksel yöntem kullanma durumu ve etkilerini ortaya çıkarmaktır. Methods: Bu çalışma tanımlayıcı tiptedir. Araştırmanın örneklemi 232 kutanöz leishmania hastası oluşturmuştur. Araştırma verileri anket formu ile toplanmıştır. Veriler tanımlayıcı istatistikler, Ki-kare testi ile phi (Φ) ve Cramer V katsayı ile değerlendirilmiştir. 0,05'ten küçük bir P değeri istatistiksel olarak anlamlı kabul edilmiştir. Results: Ankete katılan KL tanısıyla tedavi alan 96 kişinin çocuk olduğu, 136 kişinin yetişkin olduğu görülmüştür. Hastaların aile üyelerinden birisinde daha önce KL geçirme oranı %44,9 iken, hastaların %8,1’inin daha önce KL hastalığını geçirdiği saptanmıştır. KL çocuk hastalarda geleneksel yöntem kullanılmazken, yetişkin hastaların %44,1’inin hastalığı için geleneksel yöntem kullandığı saptanmıştır. Geleneksel yöntem kullanan hastalar en çok (%48,3) aktardan alınan hazır merhemleri yara yerine sürmüştür. Hastaların %66,7’sinin kullandığı geleneksel yöntemden zarar görmüştür. 45 yaş ve altındaki hastaların %10,8’i, 45 yaş üstü hastaların %74,6’sı geleneksel yöntem kullanmış (p<0,05), yaş ile geleneksel yöntem kullanma durumu arasında negatif orta bir ilişkinin olduğu görülmüştür (Φ =-0,64). Okuryazar olmayan hastaların %89,5’i geleneksel yöntem kullanırken, ortaokul ve üstü eğitime sahip hastaların ise %13,6’sının geleneksel yöntem kullandığı saptanmıştır (p<0,05, V=0,57). Yüzünde yarası olan hastalar daha çok geleneksel yöntem kullanmıştır (p<0,05, V=0,25). Conclusions: Bu araştırma, Şanlıurfa İlinde kutanöz leishmania hastalığının hala önemli bir halk sağlığı sorunu olduğunu, geleneksel yöntemlerin yetişkin hastalar üzerinde olumsuz etkisi olduğunu göstermiştir.

Anahtar Kelimeler

• : Kutanöz Leishmania
• Şark Çıbanı
• Geleneksel Yöntem
• Halk Sağlığı

Kaynakça

1. 1. Oryan A, Akbari M. Worldwide risk factors in leishmaniasis. Asian Pacific Journal of Tropical Medicine. 2016; 9(10): 925-932.
2. 2. Abdrebbi S-B, Henaoui L, Chabni N, Meguenni K. Cutaneous Leishmaniasis: endemic regions and epidemiological char-acteristics of cases declared at University Hospital Center of Tlemcen, Algeria. Journal of Pharmacy and Pharmacolo-gy. 2019; 7: 249-254. Doi: 10.17265/2328-2150/2019.05.004
3. 3. Harman M. Cutaneous leishmaniasis. Turk J Dermatol. 2015; 9: 168-76. Doi: 10.4274/tdd.2880
4. 4. World Health Organization. WHO bi-regional consultation on the status of Leishmaniasis control and surveillance in East Africa (No. WHO/CDS/NTD/IDM/2018.06).
5. 5. Gürel M-S, Yeşilova Y, Ölgen M-K, Özbel Y. Cutaneous Leishmaniasis in Turkey. Turkiye Parazitol Derg. 2012; 36: 121-9. Doi:10.5152/tpd.2012.29
6. 6. Uribe-Restrepo A, Cossio A, Desai MM, Da´valos D, Castro M-D-M. Interventions to treat cutaneous leishmaniasis in children: A systematic review. PLoS Negl Trop Dis. 2018;12(12): e0006986. Doi:10.1371/journal. and.0006986.
7. 7. De Vries H-J, Schallig H-D. Cutaneous leishmaniasis: a 2022 updated narrative review into diagnosis and man-agement developments. American Journal of Clinical Der-matology. 2022; 23(6): 823-840. Doi:10.1007/s40257-022-00726-8
8. 8. Azim M, Khan SA, Ullah S, Ullah S, Anjum SI. Therapeutic advances in the topical treatment of cutaneous leishmani-asis: A review. PLoS Negl Trop Dis. 2021; 15(3): e0009099. Doi: 10.1371/journal.pntd.0009099

9. 9. Abadías-Granado I, Diago A, Cerro P-A, Palma-Ruiz A-M, Gilaberte Y. Cutaneous and mucocutaneous leishmaniasis. Actas Dermo-Sifiliográficas (English Edition), 2021; 112(7): 601-618.
10. 10. Sghaier R-M, Benhnini F, Guerfali F-Z, Attia H, Bali A, Zaatour A, et al. Healed lesions of human cutaneous leishmaniasis caused by Leishmania major do not shelter persistent residual parasites. Frontiers in Cellular and In-fection Microbiology. 2022; 12: 839216.
11. 11. Zeyrek F-Y, Gürses G, Uluca N, Doni N-Y, Toprak Ş, Yeşilova Y, Çulha G. Is the agent of cutaneous leishmania-sis in Sanliurfa changing? First cases of Leishmania majör. Turkiye Parazitol Derg. 2014;38:270-4. Doi: 10.5152/tpd.2014.3820
12. 12. Doni N-Y, Gürses G, Dikme R, Şimşek Z, Muratoğlu M, Zeyrek F-Y, ve ark. Investigation of cutaneous leishmaniasis by active screening in primary schools in Sanliurfa, Turkey. Mikrobiyol Bul. 2016;50(4):559-568. Doi: 10.5578/mb.32180.
13. 13. Gökler M-E, Durmuş H, Ateşoğlu A. Evaluation and risk mapping of cutaneous leishmaniasis cases between 2007 and 2017 in Şanlıurfa, Turkey. Klimik Derg. 2020;33(3): 248-54. Doi: 10.5152/kd.2020.51
14. 14. Karimkhani C, Wanga V, Coffeng LE, Naghavi P, Dellavalle RP, Naghavi M. Global burden of cutaneous leishmaniasis: a cross-sectional analysis from the Global Burden of Dis-ease Study 2013. The Lancet Infectious Diseases. 2016; 16(5): 584-591.
15. 15. Bennis I, Thys S, Filali H, De Brouwere V, Sahibi H, Boela-ert M. Psychosocial impact of scars due to cutaneous leishmaniasis on high school students in Errachidia prov-ince, Morocco. Infectious Diseases Of Poverty. 2017;6(1):1-8.
16. 16. Nilforoushzadeh M-A, Jaffary F, Moradi S, Derakhshan R, Haftbaradaran E. Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis. BMC complementary and al-ternative medicine. 2007;7(1):1-4. Doi:10.1186/1472-6882-7-13
17. 17. Biçer İ, Yalçın Balçık P. Tradıtıonal and complementary medıcıne: ınvestıgatıon of Turkey and the selected coun-trıes. Hacettepe Journal of Health Administration. 2019;22(1):245-257
18. 18. Alahverdi Ş. Psychosocial status and changes in quality of life level and the factors affecting this in 6-17 age group cutaneous leishmaniasis patients before and after cutane-ous leishmaniasis treatment. Specialty Thesis, Department of Public Health in Harran University. 2020. Şanlıurfa, Tur-key.
19. 19. Bayazıt Y, Özcebe H. Incıdence and prevalence of cutane-ous leıshmanıasıs ın central part of Şanlıurfa provınce. Türk Hij Den Biyol Derg. 2004;61(1,2,3):9-14.